Orchestra BioMed Holdings, Inc. (OBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 198.15M |
| Enterprise Value | 179.42M |
| P/E Ratio | -5.41 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 10.04 |
| Price/Book Ratio | 11.63 |
| Enterprise/Revenue | 10.08 |
| Enterprise/EBITDA | -5.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -1.85 |
| Operating Margin | -1.81 |
| Return On Assets | -0.51 |
| Return On Equity | -1.26 |
| Revenue | 33.48M |
| Revenue/Share | 0.5 |
| Gross Profit | 33.29M |
| EBITDA | -51.23M |
| Net Income | -52.7M |
| Diluted EPS | -1.11 |
| Total Cash | 109.96M |
| Total Cash/Share | 1.72 |
| Total Debt | 21.77M |
| Total Debt/Equity | 0.74 |
| Current Ratio | 8.26 |
| Book Value Per Share | 0.46 |
| 52-Week Change | 110.2 |
| 52-Week High | 5.78 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 4.16 |
| Moving Average 200 Days | 4.22 |
| Average Volume | 343,069 |
| Shares Outstanding | 59.88M |
| % Held by Institutions | 60.15 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |